Background: Schizophrenia is a disorder with a heterogeneous genetic and neurobiological background that influences early brain development. The symptoms is the behavioural outcome of deviations in early neurodevelopment, including prenatal insults such as obstetric complications (OC). OC have been linked to an increased risk for schizophrenia in offspring, especially in early-onset schizophrenia (EOS). Extensive cognitive deficits occur in EOS, whereof executive function is one of the best documented. Cognitive dysfunction reflects underlying abnormalities in the brain neurodevelopment, and is considered to be an intermediate variable between OC and schizophrenia. Our research group (Teigset et al, 2016) is the only study that has investigated the relationship between OC and cognition in EOS. This study aimed to examine the frequency of OC in EOS compared to controls, and also investigate the relationship between OC and neurocognitive dysfunction. In the present presentation we will focus upon executive function and report the findings when comparing the same sample of patients and controls as in the Teigset et al study. Methods: Nineteen EOS patients and 53 healthy controls were tested with the MATRICS Consensus Cognitive Battery(MCCB), and two tests for assessment of executive functioning. The selected subtests for measuring executive function were the D-KEFS Color Word Interference Test (Stroop) and the Wisconsin Card Sorting Test. WCST assesses perseverative responses and failure to maintain set, and the Stroop assesses time in seconds for completing the Inhibition and Switching conditions. The cognitive measures were combined with data from the Norwegian Birth Registry (NMBR). Information on OC was collected from the NMBR containing information about all births in Norway, including information about maternal health before and during pregnancy, and any complications arising during pregnancy or birth. The registry includes information about medication during pregnancy, labor interventions, birth complications, maternal complications after birth, whether this was a live birth, any diagnoses in the child or evidence of congenital abnormalities. Results: Group differences in OC were studied with Student's t-tests and Chi-square tests. The association between OC and cognitive function were studied using linear regression analyses. The results indicated no group differences in OC in EOS and healthy controls. However, a shorter gestational length in the EOS group led to significant decreases in the overall neurocognitive composite score (MCCB), in processing speed and in the two executive function tasks. Discussion: Our findings indicate that a shorter gestational length did not increase the risk for developing EOS, but was significantly associated with the cognitive difficulties in this group. In particular, executive functioning were affected, a finding in line with those of Brown et al (2009), showing that prenatal infections were associated with impaired executive function. Interestingly, reductions in neurocognitive performance among those exposed to OC was less extensive in the healthy control group with the same labor-conditions, which may indicate a greater effect of OC on neuropsychological development in schizophrenia. In conclusion, gestational length does not increase the risk for developing EOS, but significantly affects the cognitive difficulties -particularly executive function -seen among cases.
Background: Schizophrenia is a highly heritable disease, mediated through a combination of common and rare genetic variants. In addition to genetic risk, several putative environmental risk factors have been studied in the context of schizophrenia. It has been suggested that the genetic effects on the etiology of schizophrenia may be of limited explanatory power if not viewed in the context of interaction with environmental stressors. Here, in a pre-adolescent population-based sample, we used polygenic risk scores from a case-control discovery sample of the Psychiatric Genomics Consortium as indicators of genetic vulnerability to schizophrenia. In addition, hair cortisol levels were obtained as a naturalistic quantitative metric of long-term physiological stress. We examined whether cortisol levels moderated the relationship between schizophrenia polygenic risks scores and pre-adolescent brain structure. Methods: This study was embedded in the Generation R Study, a prospective birth cohort from the Netherlands. Polygenic risk scores for schizophrenia were calculated in children of European ancestry only. P-value thresholds for inclusion of genetic variants in the polygenic risk score varied between P < 0.001 and P < 1. Hair cortisol was collected when the children were approximately 6 years old. At age 9 years, children underwent a magnetic resonance imaging (MRI) procedure to assess volumetric brain measures. After genetic and neuroimaging quality control procedures, the final sample consisted of 522 participants. Linear regression models were conducted to examine the associations between schizophrenia polygenic risk scores, hair cortisol levels, and brain volumes. All analyses were adjusted for age, sex, hair color, hair product use and four genetic principal components. Results: Schizophrenia polygenic risk scores were not associated with hair cortisol levels (P-value threshold [PT] < 0.001, β = -0.03, 95% confidence interval [CI] -0.11 -0.05, P = 0.441), cortical grey matter volume (PT < 0.001, β = -0.03, 95% CI -0.11 -0.05, P = 0.457) or cerebral white matter volume (PT < 0.001, β = -0.04, 95% CI -0.12 -0.04, P = 0.356). Higher schizophrenia polygenic risk scores were associated with lower total ventricle volume (PT <0.001, β = -0.10, 95% CI -0.19 --0.02, P = 0.022), including when mutually adjusted for total brain volume. Notably however, hair cortisol exhibited a positive interaction with schizophrenia risk scores in predicting total ventricle volume (PT < 0.001, β = 0.10, 95% CI 0.01 -0.18, P = 0.027), i.e. higher schizophrenia polygenic risk score and higher hair cortisol levels were associated with increased ventricle volumes. Hair cortisol was not independently associated with total ventricle volume (PT < 0.001, β = -0.05, 95% CI -0.14 -0.03, P = 0.215). Discussion: Elevated hair cortisol levels, a biological index of long-term stress, moderated the association between genetic vulnerability to schizophrenia and total cerebral ventricle volume among pre-adolescents. These findings underscore the importance of the interplay between genes and environment in shaping brain development. Using a polygenic risk score for schizophrenia, we provide novel, albeit preliminary, evidence for geneenvironment interaction between genetic risk for schizophrenia and environmental stressors in the general pre-adolescent population. This may help to elucidate underlying etiologies and possible early interventions for the psychosis spectrum. 
S199. ENHANCED OLFACTORY IDENTIFICATION IN ADOLESCENTS WITH PSYCHOTIC EXPERIENCES
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Background: The olfactory system has a widely distributed anatomical network reaching both cortical and subcortical structures (Milardi et al., 2017) . Olfactory dysfunction has been associated with schizophrenia (Moberg & Turetsky, 2003) , where deficits in odour identification (Seidman et al., 1997) , odor detection threshold sensitivity (Serby et al., 1990 ) and odour memory (Wu et al., 1993) can be seen early in the course of the disorder and persist with illness duration (Rupp, 2010 Results: Performance on the BSIT was compared between participants who reported any psychotic experiences (PE) (N=71), and those who did not (N=69). We examined total score and scores for individual smell types, using ANOVA, and co-varied for age and gender. Results: A significant group difference was found when both age and gender were co-varied for, in which the PE group performed significantly better on the BSIT (F=5.56, p= 0.02), and one of the individual twelve odours (''paint-thinner'') of the BSIT also was significantly better identified by the PE group (F=7.53, p=0.007). When examined in terms of correlations with psychotic symptoms, BSIT scores were found to significantly correlate with Grandiosity, one of the eight categories of the Adolescent Psychotic-Like Symptoms Screener (APSS) (p=0.004). Discussion: Moberg et al. (2013) report that positive symptoms of psychosis may be moderating our results, where it was hypothesized that this early olfactory hypersensitivity is due to increased vigilance of external and internal stimuli. Corcoran et al. (2005) similarly found that the presence of features associated with mania, such as grandiosity, was associated with better outcomes in smell identification tests. We hope to extend our analysis to search for neuroanatomical and neuropsychological correlates of these olfactory performance scores in young people with and without psychotic symptoms, as well as looking more indepth at positive symptoms reported by the PE group and their possible associations with this increased hypersensitivity in olfactory identification. The current research is hoped to capture some of the earliest olfactory changes associated with psychosis vulnerability as a possible biomarker. The study employs a novel participant cohort whom are considered an extended psychosis phenotype and at this point only exhibit psychotic symptoms, but remain at an increased risk of the development of psychosis in adulthood.
S200. HYPOVITAMINOSIS D IN SCHIZOPHRENIA: PREVALENCE AND ASSOCIATED CLINICAL CHARACTERISTICS
Rahma Nefzi* It is within this framework that this study aims to explore the relationship between vitamin D levels and the clinical characteristics in a cohort of Tunisian patients with schizophrenia.
Methods:
A cross-sectional and retrospective descriptive study was conducted at the "F" psychiatry department at the Razi Hospital, Manouba over a twelve-month period from June 1st, 2015 to May 31st, 2016, including 80 patients with schizophrenia in period of clinical remission. The evaluation focused on sociodemographic and clinical characteristics. A dosage of vitamin D was performed. Results: The patients had an average age of 42.5 years and 70% were male. The average vitamine D level was 10,57ng/ml ±5,9. 49% of patients had vitamin D insufficiency (between 10 and 30 ng/ml) and 51% had vitamin D deficiency (<10 ng/ml). Vitamin D levels had not been affected by the clinical characteristics of the disease. A negative correlation with the total score of the negative scale (p <0.001) as well as with the severity item of the clinical global impression scale (p = 0.01) were found. Discussion: A large number of research studies in immunogenetics and molecular biology have highlighted the involvement of vitamin D in the etiopathogenesis of schizophrenia through its role in the ontogenesis of dopaminergic systems and also through its intervention in the processes of neuro-protection, immunomodulation and the reduction of oxidative stress. Background: Electroconvulsive therapy (ECT) is the most popular way to stimulate brain for achieving therapeutic effects. The therapeutic effect of ECT results from the induction of a generalized seizure. The minimal amount of electrical energy needed to induce seizures is known as the seizure threshold (ST). It is commonly believed that treatment efficacy is related to stimulus dose relative to ST, but higher stimuli usually also increase unwanted side effects. Therefore, ST is an important issue in conducting ECT. Most patients including schizophrenics undergoing ECT take concomitant psychotropic drugs, but little information is available on how these drugs affect ST. Our study aimed to analyze the relationship between ST and psychotropic drugs in patients treated with ECT. Methods: We retrospectively reviewed the medical charts of 43 patients who received ECT at Korea University Guro Hospital between February 2009 and June 2015. Patients with a history of seizure disorders or other medical emergent conditions were excluded. A total of fifty-eight subjects received ECT during the study period. Patients were excluded if treatment was aborted due to side effects or any other reasons before the 10th session (n=12) because we intended to investigate the ST shift during the course of consecutive ECT sessions. We included 43 subjects in the final data analysis. Patients' psychiatric disorders were diagnosed according to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-R) by at least two experienced psychiatrists. ECT was administrated with concurrent antipsychotics and antidepressants.67.4 percent of subjects were diagnosed as schizophrenia and 20.9 percent of subjects were diagnosed as major depressive disorder. We used stepwise multivariate correlation analyses for examining the associations between ST and psychotropic drugs. Data are presented as initial ST, the difference in ST between the first and 10th sessions (ΔST10th), and the mean difference in ST between the first and last sessions (mean ΔSTlast). We used chlorpromazine-equivalent dose for antipsychotics and fluoxetine-equivalent dose for antidepressants.
